Month: September 2021

vTv Therapeutics Announces Results of Multiple Ascending Dose Study and Development Plan for HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis

HPP737 exhibited favorable safety and tolerability profile, with no dose limiting gastrointestinal side effects Results build on data from previous...

Viridian Therapeutics Announces Closing of Public Offering of Shares of Common Stock and Preferred Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

WALTHAM, Mass., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for...

California, Manufacturer and Distributor of Sugar and Sugar Alternatives SQ USA has Recently Released it’s Three New Sugar Products: Xylitol, L-Arabinose, and Refined D-Xylose

City of Industry, California, Manufacturer and Distributor of sugar and sugar alternatives SQ USA has recently released it's three new...

error: Content is protected !!